This guide outlines strategies to align FDA and Health Canada approval pathways, compress timelines, avoid common pitfalls, and ensure compliance for efficient multi-jurisdictional product approvals in North America.
FDA and Health Canada updated medical device approval rules, affecting classifications, evidence, submissions (eSTAR, UDI), licensing, QMSR, and post-market requirements. Strategic compliance ensures timely market entry.
A winning North American medical device submission strategy requires mastering FDA 510(k), PMA, and Health Canada processes, implementing ISO 13485 risk management, human factors engineering, cybersecurity, and leveraging FDA eSTAR…
Call Now Button